top of page
BleeMACS information

From Santiago de Compostela, Dr. Emad Abu-Assi and Dr. Sergio Raposeiras-Roubín welcome cardiologists to BleeMACS initiative, as coordinators of this project, in order to know more about bleeding complicatons in ACS patients moreover in-hospital stay.

Follow-us
  • Facebook Long Shadow
  • Google+ Long Shadow
  • Twitter Long Shadow
  • LinkedIn Long Shadow
Scientific Advisory Commitee

  • Emad Abu-Assi, MD, PhD, FESC. Spain.

  • Sergio Raposeiras-Roubín, MD, PhD. Spain.

  • Fabrizio D´Ascenzo, MD, PhD. Italy.

  • José Henriques, MD, PhD. Netherlands.

  • Jorge Saucedo, MD, PhD, FACC. USA. 

Ongoing projects

· Rationale and Design of BleeMACS project. Coordinator: Dr. Fabrizio D´Ascenzo

· BleeMACS bleeding score. Coordinators: Dr. Sergio Raposeiras-Roubín and Dr. Emad Abu-Assi.

· Prevalence and outcome of patients with Cancer and Acute Coronary Syndrome: a BleeMACS sub-study. Coordinator: Dr. Mario Iannaconne

· Impact of Concomitant Proton Pump Inhibitor and P2Y12 receptor antagonist on Cardiovascular Outcomes in Patients with ACS after PCI. Coordinator: Dr. Yan Yan.

· Impact of blood transfusion on in hospital myocardial infarctions according to patterns of Acute Coronary Syndrome: insights from the BleeMACS registry. Coordinator: Dr. Sebastiano Gili. 

· Prediction of bleeding in the elderly: a sub-study form BleeMACS registry. Coordinator: Dr. Albert Ariza.

· Single versus double antiplatelet therapy in patients at high bleeding risk with acute coronary syndrome undergoing Plain-Only Balloon Angioplasty: a sub-analysis of BleeMACs study registry. Coordinator: Dr. Mario Iannaconne.

 

 

© 2015 by BleeMACS investigators

bottom of page